Skip to main content
PMC home page
Annals of Surgery logoLink to Annals of Surgery
. 1989 Feb;209(2):249–253. doi: 10.1097/00000658-198902000-00018

Treatment and survival of female patients with nonpalpable breast carcinoma.

J G Tinnemans 1, T Wobbes 1, R Holland 1, J H Hendriks 1, R F Van der Sluis 1, H H De Boer 1
PMCID: PMC1493899  PMID: 2537064

Abstract

Since 1971, 151 nonpalpable breast cancers (100 invasive carcinomas, 39 in situ ductal carcinomas, and twelve lobular carcinomas in situ) have been diagnosed and treated at the St. Radboud University Hospital. Of the 100 clinically occult invasive carcinomas, 53 had pathologic diameters of more than 10 mm, 29 were of sizes between 6 and 10 mm, and 18 were tumors of 5 mm or less. Residual tumor outside the "excisional" biopsy cavity was encountered in 76 of the 118 mastectomy specimens (64.4%) fully capable of evaluation. Invasive residual tumor would have been left behind in 34 of 86 mastectomy specimens (39.5%). Of 27 axillas studied, no patient with in situ carcinoma had evidence of axillary lymph node metastases. Invasive carcinoma, however, showed axillary lymph node involvement in 7.7% of mastectomy specimens when the size of the primary tumor was not more than 5 mm, in 12.5% when the size was between 6 and 10 mm, and in 29.5% when the primary tumor was more than 10 mm in diameter. The 10-year recurrence-free survival (RFS) of patients with clinically occult invasive carcinomas greater than 10 mm in size was 71.9% and differed significantly from the 90.9% for patients with the invasive tumors less than or equal to 5 mm, as well as from the 100% RFS of patients with invasive tumors of between 6 and 10 mm and noninvasive tumors. Although the 10-year RFS was 92.6% for the patients with negative axillary nodes and 80.0% for the patients with positive axillary nodes, this difference did not reach statistical significance. However, the disease-specific overall survival after 10 years was significantly different between node-negative patients (96.4%) and node-positive patients (78.8%). Multivariate analysis disclosed that the relationship between size of the primary tumor and RFS was independent of the presence of axillary lymph node metastases. In conclusion, the validity of the concept of minimal breast cancer has been re-enforced. However, the results of this study suggest that the upper limit of the original definition of minimal breast cancer is too narrow and should be extended, so that, apart from the noninvasive tumors--regardless of their size--all invasive tumors having a maximum diameter less than or equal to 10 mm should be regarded as minimal breast cancers.

Full text

PDF
249

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ashikari R., Hajdu S. I., Robbins G. F. Intraductal carcinoma of the breast. (1960-1969). Cancer. 1971 Nov;28(5):1182–1187. doi: 10.1002/1097-0142(1971)28:5<1182::aid-cncr2820280515>3.0.co;2-h. [DOI] [PubMed] [Google Scholar]
  2. Beahrs O. H., Smart C. R. Diagnosis of minimal breast cancers in the BCDDP: the 66 questionable cases. Cancer. 1979 Mar;43(3):848–850. doi: 10.1002/1097-0142(197903)43:3<848::aid-cncr2820430310>3.0.co;2-1. [DOI] [PubMed] [Google Scholar]
  3. Bedwani R., Vana J., Rosner D., Schmitz R. L., Murphy G. P. Management and survival of female patients with "minimal" breast cancer: as observed in the long-term and short-term surveys of the American College of Surgeons. Cancer. 1981 Jun 15;47(12):2769–2778. doi: 10.1002/1097-0142(19810615)47:12<2769::aid-cncr2820471202>3.0.co;2-7. [DOI] [PubMed] [Google Scholar]
  4. Collette H. J., Day N. E., Rombach J. J., de Waard F. Evaluation of screening for breast cancer in a non-randomised study (the DOM project) by means of a case-control study. Lancet. 1984 Jun 2;1(8388):1224–1226. doi: 10.1016/s0140-6736(84)91704-5. [DOI] [PubMed] [Google Scholar]
  5. Egan R. L. Multicentric breast carcinomas: clinical-radiographic-pathologic whole organ studies and 10-year survival. Cancer. 1982 Mar 15;49(6):1123–1130. doi: 10.1002/1097-0142(19820315)49:6<1123::aid-cncr2820490610>3.0.co;2-r. [DOI] [PubMed] [Google Scholar]
  6. Frazier T. G., Copeland E. M., Gallager H. S., Paulus D. D., Jr, White E. C. Prognosis and treatment in minimal breast cancer. Am J Surg. 1977 Jun;133(6):697–701. doi: 10.1016/0002-9610(77)90156-8. [DOI] [PubMed] [Google Scholar]
  7. Haagensen C. D., Lane N., Lattes R., Bodian C. Lobular neoplasia (so-called lobular carcinoma in situ) of the breast. Cancer. 1978 Aug;42(2):737–769. doi: 10.1002/1097-0142(197808)42:2<737::aid-cncr2820420247>3.0.co;2-t. [DOI] [PubMed] [Google Scholar]
  8. Holland R., Mravunac M., Hendriks J. H., Bekker B. V. So-called interval cancers of the breast. Pathologic and radiologic analysis of sixty-four cases. Cancer. 1982 Jun 15;49(12):2527–2533. doi: 10.1002/1097-0142(19820615)49:12<2527::aid-cncr2820491220>3.0.co;2-e. [DOI] [PubMed] [Google Scholar]
  9. Holland R., Veling S. H., Mravunac M., Hendriks J. H. Histologic multifocality of Tis, T1-2 breast carcinomas. Implications for clinical trials of breast-conserving surgery. Cancer. 1985 Sep 1;56(5):979–990. doi: 10.1002/1097-0142(19850901)56:5<979::aid-cncr2820560502>3.0.co;2-n. [DOI] [PubMed] [Google Scholar]
  10. Letton A. H., Mason E. M. Routine breast screening. Survival after 10.5 years follow-up. Ann Surg. 1986 May;203(5):470–473. doi: 10.1097/00000658-198605000-00004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Lundgren B. Observations on growth rate of breast carcinomas and its possible implications for lead time. Cancer. 1977 Oct;40(4):1722–1725. doi: 10.1002/1097-0142(197710)40:4<1722::aid-cncr2820400448>3.0.co;2-2. [DOI] [PubMed] [Google Scholar]
  12. Nevin J. E., Pinzón G., Morán T. J., Baggerly J. T. Minimal breast carcinoma. Am J Surg. 1980 Mar;139(3):357–359. doi: 10.1016/0002-9610(80)90293-7. [DOI] [PubMed] [Google Scholar]
  13. Peters T. G., Donegan W. L., Burg E. A. Minimal breast cancer: a clinical appraisal. Ann Surg. 1977 Dec;186(6):704–710. doi: 10.1097/00000658-197712000-00007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Rodes N. D., Lopez M. J., Pearson D. K., Blackwell C. W., Lankford H. D. The impact of breast cancer screening on survival. A 5- to 10-year follow-up study. Cancer. 1986 Feb 1;57(3):581–585. doi: 10.1002/1097-0142(19860201)57:3<581::aid-cncr2820570331>3.0.co;2-x. [DOI] [PubMed] [Google Scholar]
  15. Rosen P. P. Axillary lymph node metastases in patients with occult noninvasive breast carcinoma. Cancer. 1980 Sep 1;46(5):1298–1306. doi: 10.1002/1097-0142(19800901)46:5<1298::aid-cncr2820460535>3.0.co;2-2. [DOI] [PubMed] [Google Scholar]
  16. Schwartz G. F., Feig S. A., Rosenberg A. L., Patchefsky A. S., Schwartz A. B. Staging and treatment of clinically occult breast cancer. Cancer. 1984 Mar 15;53(6):1379–1384. doi: 10.1002/1097-0142(19840315)53:6<1379::aid-cncr2820530627>3.0.co;2-r. [DOI] [PubMed] [Google Scholar]
  17. Shwartz M. Estimates of lead time and length bias in a breast cancer screening program. Cancer. 1980 Aug 15;46(4):844–851. doi: 10.1002/1097-0142(19800815)46:4<844::aid-cncr2820460434>3.0.co;2-5. [DOI] [PubMed] [Google Scholar]
  18. Tabár L., Fagerberg C. J., Gad A., Baldetorp L., Holmberg L. H., Gröntoft O., Ljungquist U., Lundström B., Månson J. C., Eklund G. Reduction in mortality from breast cancer after mass screening with mammography. Randomised trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare. Lancet. 1985 Apr 13;1(8433):829–832. doi: 10.1016/s0140-6736(85)92204-4. [DOI] [PubMed] [Google Scholar]
  19. Tinnemans J. G., Wobbes T., Hendriks J. H., van der Sluis R. F., Lubbers E. J., de Boer H. H. Localization and excision of nonpalpable breast lesions. A surgical evaluation of three methods. Arch Surg. 1987 Jul;122(7):802–806. doi: 10.1001/archsurg.1987.01400190068013. [DOI] [PubMed] [Google Scholar]
  20. Tinnemans J. G., Wobbes T., Holland R., Hendriks J. H., van der Sluis R. F., Lubbers E. J., de Boer H. H. Mammographic and histopathologic correlation of nonpalpable lesions of the breast and the reliability of frozen section diagnosis. Surg Gynecol Obstet. 1987 Dec;165(6):523–529. [PubMed] [Google Scholar]
  21. Tinnemans J. G., Wobbes T., van der Sluis R. F., Lubbers E. J., de Boer H. H. Multicentricity in nonpalpable breast carcinoma and its implications for treatment. Am J Surg. 1986 Mar;151(3):334–338. doi: 10.1016/0002-9610(86)90462-9. [DOI] [PubMed] [Google Scholar]
  22. Verbeek A. L., Hendriks J. H., Holland R., Mravunac M., Sturmans F., Day N. E. Reduction of breast cancer mortality through mass screening with modern mammography. First results of the Nijmegen project, 1975-1981. Lancet. 1984 Jun 2;1(8388):1222–1224. doi: 10.1016/s0140-6736(84)91703-3. [DOI] [PubMed] [Google Scholar]
  23. Wanebo H. J., Huvos A. G., Urban J. A. Proceedings: Treatment of minimal breast cancer. Cancer. 1974 Feb;33(2):349–357. doi: 10.1002/1097-0142(197402)33:2<349::aid-cncr2820330208>3.0.co;2-4. [DOI] [PubMed] [Google Scholar]

Articles from Annals of Surgery are provided here courtesy of Lippincott, Williams, and Wilkins

RESOURCES